Fonseca R - Search Results

1

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.

Reeder CB, Reece DE, Kukreti V, Chen C, Trudel S, Hentz J, Noble B, Pirooz NA, Spong JE, Piza JG, Zepeda VH, Mikhael JR, Leis JF, Bergsagel PL, Fonseca R, Stewart AK. Reeder CB, et al. Among authors: fonseca r. Leukemia. 2009 Jul;23(7):1337-41. doi: 10.1038/leu.2009.26. Epub 2009 Feb 19. Leukemia. 2009. PMID: 19225538 Free PMC article. Clinical Trial.

2

Thalidomide in the treatment of relapsed multiple myeloma.

Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. Mayo Clin Proc. 2000 Sep;75(9):897-901. doi: 10.4065/75.9.897. Mayo Clin Proc. 2000. PMID: 10994824

3

Effect of complete response on outcome following autologous stem cell transplantation for myeloma.

Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA. Rajkumar SV, et al. Among authors: fonseca r. Bone Marrow Transplant. 2000 Nov;26(9):979-83. doi: 10.1038/sj.bmt.1702640. Bone Marrow Transplant. 2000. PMID: 11100277

4

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW. Fonseca R, et al. Leukemia. 2001 Jun;15(6):981-6. doi: 10.1038/sj.leu.2402125. Leukemia. 2001. PMID: 11417487 Clinical Trial.

5

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA, Kyle RA, Greipp PR, Gertz MA, Witzig TE. Rajkumar SV, et al. Among authors: fonseca r. Leukemia. 2001 Aug;15(8):1274-6. doi: 10.1038/sj.leu.2402183. Leukemia. 2001. PMID: 11480571 Clinical Trial.

6

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.

Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Dávila R, González-Paz N, Winkler JM, Kyle RA, Gertz MA, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA, Greipp PR, Fonseca R. Debes-Marun CS, et al. Among authors: fonseca r. Leukemia. 2003 Feb;17(2):427-36. doi: 10.1038/sj.leu.2402797. Leukemia. 2003. PMID: 12592343

7

Thalidomide as initial therapy for early-stage myeloma.

Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Fonseca R, Geyer SM, Iturria N, Kumar S, Lust JA, Kyle RA, Greipp PR, Witzig TE. Rajkumar SV, et al. Among authors: fonseca r. Leukemia. 2003 Apr;17(4):775-9. doi: 10.1038/sj.leu.2402866. Leukemia. 2003. PMID: 12682636 Clinical Trial.

8

Many and multiple myeloma(s).

Fonseca R. Fonseca R. Leukemia. 2003 Oct;17(10):1943-4. doi: 10.1038/sj.leu.2403090. Leukemia. 2003. PMID: 14513042 Review. No abstract available.

9

Expression of VEGF and its receptors by myeloma cells.

Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: fonseca r. Leukemia. 2003 Oct;17(10):2025-31. doi: 10.1038/sj.leu.2403084. Leukemia. 2003. PMID: 14513053

10

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

Kumar S, Witzig TE, Dispenzieri A, Lacy MQ, Wellik LE, Fonseca R, Lust JA, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: fonseca r. Leukemia. 2004 Mar;18(3):624-7. doi: 10.1038/sj.leu.2403285. Leukemia. 2004. PMID: 14749707 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,489 results

Search Page

Filters